Creating functional human tissues on demand via 3D bio-printing and tissue engineering.
Currently Operating in Nine Regions
Press Mentions

August 3, 2022
Bloomberg New Economy Announces 2022 Class of Catalysts
The 28 people moving the world toward a more equitable, sustainable future.
Read on Bloomberg.com »
November 15, 2022
Tamer Mohamed, CEO of Aspect Biosystems, is turning sci-fi into reality
Bloomberg New Economy Catalyst celebrates the world’s brightest thinkers and innovators who are accelerating solutions at the leading edge of technology and policy. These are the innovations making...
Read on YouTube »
July 21, 2020
The B.C. engineer behind 3D-printed human tissues
Competitive spirit has driven engineer-turned-entrepreneur Tamer Mohamed’s success with Aspect Biosystems
Read on Business in Vancouver »
January 9, 2020
Aspect Biosystems Raises US$20M in Series A Financing
Aspect Biosystems, a biotechnology company advancing microfluidic 3D bioprinting of human tissues, raised US $20m in Series A financing. Investors include Pangaea Ventures, Pallasite Ventures,...
Read on FinSMEs »
June 5, 2019
Aspect Biosystems Partners with Merck, GSK, and McGill University to Enable Development of Immuno-Oncology Therapeutics
This $2.2M project is made possible by contributions from CQDM, CCS, Merck, GSK, Aspect Biosystems, and McGill University.
Read more »Work at Aspect Biosystems
Posted September 12, 2023
Quality Control Associate, Microbiology
Vancouver, BC, Canada
View Listing »Posted July 28, 2023
Process Development Associate, Bioprinting
Vancouver, BC, Canada/Vancouver, BC, Canada
View Listing »Posted July 1, 2023
Research Associate, In Vivo & Tissue Analysis
Vancouver, BC, Canada
View Listing »Posted June 21, 2023
Process Development Associate
Vancouver, BC, Canada/Vancouver, BC, Canada
View Listing »More Ventures in Health
Get the Unreasonable Newsletter
Get monthly updates on Aspect Biosystems and over 370 other ventures working to solve the world's toughest problems.